Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study
- PMID: 25225211
- DOI: 10.1161/HYPERTENSIONAHA.114.04221
Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study
Abstract
In the pathogenesis of cardiovascular events, interaction between risk factors has seldom been identified. However, endothelial dysfunction on the one hand and type 2 diabetes mellitus, impaired glucose metabolism (IGM), and insulin resistance on the other may act synergistically (ie, interact) in the development of cardiovascular disease. We therefore investigated the interaction between endothelial dysfunction and type 2 diabetes mellitus, IGM, and insulin resistance with regard to risk of cardiovascular events. In a prospective population-based cohort (n=445; 69 years; 55% women; 23% type 2 diabetes mellitus, 28% IGM [by design]), endothelial dysfunction (brachial artery flow-mediated dilatation), glucose tolerance (oral glucose tolerance test), and insulin sensitivity (homeostasis model assessment for insulin resistance [HOMA2-IR]) were determined. After a median follow-up of 7.6 years, 106 participants had had a cardiovascular event. After adjustments, 1 SD less flow-mediated dilatation was associated with cardiovascular events in type 2 diabetes mellitus (hazard ratio 1.69 [95% confidence interval, 1.14-2.52]) and IGM (1.50 [0.95-2.37]) and among those in the highest HOMA2-IR tertile (1.92 [1.42-2.60]), but not in normal glucose metabolism (0.85 [0.63-1.16]) or among those in the lower 2 HOMA2-IR tertiles combined (0.85 [0.65-1.12]). Interaction between flow-mediated dilatation and type 2 diabetes mellitus, IGM, or insulin resistance was present on an additive (relative excess risk caused by interaction>0) and on a multiplicative scale (P interaction<0.05). Endothelial dysfunction and type 2 diabetes mellitus, IGM, or insulin resistance synergistically increase cardiovascular event risk. This identifies endothelial dysfunction as a key therapeutic target in these individuals.
Keywords: cardiovascular diseases; endothelium; epidemiology; insulin resistance; prospective studies; type 2 diabetes mellitus.
© 2014 American Heart Association, Inc.
Comment in
-
Endothelial dysfunction potentially interacts with impaired glucose metabolism to increase cardiovascular risk.Hypertension. 2014 Dec;64(6):1192-3. doi: 10.1161/HYPERTENSIONAHA.114.04348. Epub 2014 Sep 15. Hypertension. 2014. PMID: 25225204 Free PMC article. No abstract available.
Similar articles
-
The metabolic syndrome in elderly individuals is associated with greater muscular, but not elastic arterial stiffness, independent of low-grade inflammation, endothelial dysfunction or insulin resistance--The Hoorn Study.J Hum Hypertens. 2009 Nov;23(11):718-27. doi: 10.1038/jhh.2009.8. Epub 2009 Mar 12. J Hum Hypertens. 2009. PMID: 19279658
-
Family history of diabetes is a major determinant of endothelial function.J Am Coll Cardiol. 2006 Jun 20;47(12):2456-61. doi: 10.1016/j.jacc.2006.02.045. Epub 2006 May 30. J Am Coll Cardiol. 2006. PMID: 16781373
-
Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study.Kidney Int Suppl. 2004 Nov;(92):S42-4. doi: 10.1111/j.1523-1755.2004.09211.x. Kidney Int Suppl. 2004. PMID: 15485416 Review.
-
Endothelial dysfunction potentially interacts with impaired glucose metabolism to increase cardiovascular risk.Hypertension. 2014 Dec;64(6):1192-3. doi: 10.1161/HYPERTENSIONAHA.114.04348. Epub 2014 Sep 15. Hypertension. 2014. PMID: 25225204 Free PMC article. No abstract available.
-
Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):423-36. doi: 10.1002/dmrr.634. Diabetes Metab Res Rev. 2006. PMID: 16506274 Review.
Cited by
-
Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus.Cardiovasc Diabetol. 2021 Mar 13;20(1):64. doi: 10.1186/s12933-021-01257-y. Cardiovasc Diabetol. 2021. PMID: 33714276 Free PMC article.
-
Multiple Cell Signalling Pathways of Human Proinsulin C-Peptide in Vasculopathy Protection.Int J Mol Sci. 2020 Jan 18;21(2):645. doi: 10.3390/ijms21020645. Int J Mol Sci. 2020. PMID: 31963760 Free PMC article. Review.
-
Discovering hidden patterns: Association rules for cardiovascular diseases in type 2 diabetes mellitus.World J Methodol. 2024 Jun 20;14(2):92608. doi: 10.5662/wjm.v14.i2.92608. eCollection 2024 Jun 20. World J Methodol. 2024. PMID: 38983667 Free PMC article.
-
Relationship between the 10-Year Risk for Atherosclerotic Cardiovascular Disease and the Dietary Inflammatory Index among Korean Adults Based on the Seventh Korea National Health and Nutrition Examination Survey (KNHANES).Biomed Res Int. 2020 May 26;2020:8196798. doi: 10.1155/2020/8196798. eCollection 2020. Biomed Res Int. 2020. PMID: 32596379 Free PMC article.
-
Exercise training and endothelial function in patients with type 2 diabetes: a meta-analysis.Cardiovasc Diabetol. 2018 May 2;17(1):64. doi: 10.1186/s12933-018-0711-2. Cardiovasc Diabetol. 2018. PMID: 29720185 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical